These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Check the appropriate box:
|
|
|
o
|
Preliminary Proxy Statement
|
|
o
|
Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
|
|
x
|
Definitive Proxy Statement
|
|
o
|
Definitive Additional Materials
|
|
o
|
Soliciting Material Pursuant to §240.14a-12
|
|
x
|
No fee required.
|
|
o
|
Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11.
|
| 1 ) |
Title of each class of securities to which transaction applies:
|
|
| 2 ) |
Aggregate number of securities to which transaction applies:
|
|
|
3)
|
Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined):
|
|
|
4)
|
Proposed maximum aggregate value of transaction:
|
|
|
5)
|
Total fee paid:
|
|
o
|
Fee paid previously with preliminary materials.
|
|
|
o
|
Check box if any part of the fee is offset as provided by Exchange Act Rule 240-0.11 and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing.
|
|
|
1
|
)
|
Amount Previously Paid:
|
|
2
|
)
|
Form, Schedule or Registration Statement No.:
|
|
3
|
)
|
Filing Party:
|
|
4
|
)
|
Date Filed:
|
|
Sincerely,
|
|
|
/s/Mark E. Schwarz
|
|
|
Mark E. Schwarz
|
|
|
Chairman of the Board
|
|
|
and Executive Chairman
|
|
|
1.
|
to elect seven directors to serve until the next Annual Meeting of Stockholders and until their successors are duly elected and qualify;
|
|
|
2.
|
to ratify the appointment of Montgomery Coscia Greilich, LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2014 (the “Auditor Ratification Proposal”); and
|
|
|
3.
|
to transact such other business as may properly be brought before the Annual Meeting.
|
|
By Order of the Board of Directors
|
|
|
/s/Mark E. Schwarz
|
|
|
Mark E. Schwarz
|
|
|
Chairman of the Board
|
|
|
and Executive Chairman
|
| Page | |
|
Questions and Answers About the Annual Meeting and Voting
|
1
|
|
Security Ownership of Certain Beneficial Owners and Management
|
6
|
|
Proposal No. 1 - Election of Directors
|
7
|
|
Directors, Nominees for Election to the Board and Named Executive Officers
|
8
|
|
Arrangements Regarding Nomination for Election to the Board
|
11
|
|
Transactions with Related Persons
|
14
|
|
Involvement in Certain Legal Proceedings
|
15
|
|
Family Relationships Between Directors and Executive Officers
|
15
|
|
Section 16(a) Beneficial Ownership Reporting Compliance
|
15
|
|
Vote Required
|
15
|
|
Proposal No. 2 - Ratification of Appointment of Independent Registered Public Accounting Firm
|
16
|
|
Fees Billed During Fiscal 2013 and 2012
|
16
|
|
Pre-Approval Policies and Procedures
|
16
|
|
Vote Required
|
17
|
|
Corporate Governance
|
18
|
|
Director Independence
|
18
|
|
Meetings and Committees of the Board of Directors
|
18
|
|
Director Nomination Process
|
19
|
|
Board Leadership Structure
|
20
|
|
Board Role in Risk Oversight
|
20
|
|
Code of Conduct and Ethics
|
21
|
|
Stockholder Communications with the Board
|
21
|
|
Executive Compensation
|
22
|
|
Summary Compensation Table
|
22
|
|
Employment Agreements and Arrangements
|
23
|
|
Potential Payments Upon Termination or Change in Control
|
23
|
|
Outstanding Equity Awards at Fiscal Year-End Table
|
23
|
|
Director Compensation
|
24
|
|
Equity Compensation Plan Information
|
24
|
|
Audit Committee Report
|
27
|
|
Stockholder Proposals
|
28
|
|
Requirements for Stockholder Proposals to be Considered for Inclusion in our Proxy Materials
|
28
|
|
Requirements for Stockholder Proposals Outside the Scope of Rule 14a-8
|
28
|
|
Requirements for Stockholder Nominations of Directors
|
28
|
|
Proxy Solicitation
|
29
|
|
Annual Report
|
29
|
|
Annex A
|
A-1
|
|
Q:
|
Why did I receive this Proxy Statement?
|
|
A:
|
The Board is soliciting your proxy to vote at the Annual Meeting because you were a stockholder at the close of business on November 14, 2014, the record date for the Annual Meeting (the “Record Date”), and are entitled to vote at the Annual Meeting.
|
|
Q:
|
What information is contained in this Proxy Statement?
|
|
A:
|
The information in this Proxy Statement relates to the proposals to be voted on at the Annual Meeting, the voting process, the compensation of directors and certain executive officers, and certain other required information.
|
|
Q:
|
What should I do if I receive more than one set of voting materials?
|
|
A:
|
You may receive more than one set of voting materials, including multiple copies of this Proxy Statement and multiple proxy cards or voting instruction cards. For example, if you hold your shares in more than one brokerage account, you may receive a separate voting instruction card for each brokerage account in which you hold shares. If you are a stockholder of record and your shares are registered in more than one name, you will receive more than one proxy card. Please complete, sign, date and return each proxy card and voting instruction card that you receive.
|
|
Q:
|
What is the difference between holding shares as a stockholder of record and as a beneficial owner?
|
|
A:
|
If your shares are registered directly in your name with our transfer agent, Securities Transfer Corporation (the “Transfer Agent”), you are considered, with respect to those shares, the “stockholder of record.” This Proxy Statement, our 2013 Annual Report on Form 10-K, as amended (the “2013 Annual Report”), and a proxy card have been sent directly to you by the Company.
|
|
Q:
|
What am I voting on at the Annual Meeting?
|
|
A:
|
You are voting on the following matters:
|
|
·
|
the election of seven directors to serve until the next Annual Meeting of Stockholders and until their successors are duly elected and qualify;
|
|
·
|
The Auditor Ratification Proposal – the ratification of the appointment of Montgomery Coscia Greilich, LLP (“Montgomery Coscia”) as our independent registered public accounting firm for the fiscal year ending December 31, 2014; and
|
|
·
|
the transaction of such other business as may properly be brought before the Annual Meeting.
|
|
Q:
|
How do I vote?
|
|
A:
|
You may vote using any of the following methods:
|
|
·
|
Proxy card or voting instruction card
. Be sure to complete, sign and date the card and return it in the prepaid envelope.
|
|
·
|
By telephone or the Internet
. This is allowed if you are a beneficial owner of shares and your broker, bank or nominee offers this alternative.
|
|
·
|
In person at the Annual Meeting
. All stockholders may vote in person at the Annual Meeting. You may also be represented by another person at the Annual Meeting by executing a proper proxy designating that person. If you are a beneficial owner of shares, you must obtain a legal proxy from your broker, bank or nominee and present it to the inspector of election with your ballot when you vote at the Annual Meeting.
|
|
Q:
|
What can I do if I change my mind after I vote my shares?
|
|
A:
|
If you are a stockholder of record, you may revoke your proxy at any time before it is voted at the Annual Meeting by:
|
|
·
|
sending written notice of revocation to our Corporate Secretary;
|
|
·
|
submitting a new, proper proxy dated later than the date of the revoked proxy; or
|
|
·
|
attending the Annual Meeting and voting in person.
|
|
Q:
|
What if I return a signed proxy card, but do not vote for the matters listed on the proxy card?
|
|
A:
|
If you return a signed proxy card without indicating your vote, your shares will be voted in accordance with the Board’s recommendation as follows: “FOR” the election of each of its nominees and the Auditor Ratification Proposal.
|
|
Q:
|
Can my broker vote my shares for me?
|
|
A:
|
Under the rules that govern brokers and nominees who have record ownership of shares that are held in “street name” for account holders (who are the beneficial owners of the shares), brokers and nominees have the discretion to vote such shares on routine matters, but not on other matters. Brokers and nominees will not have discretionary authority to vote on the election of directors, but will have discretionary authority to vote on the Auditor Ratification Proposal. Please vote your proxy so your vote can be counted.
|
|
Q:
|
Can my shares be voted if I do not return my proxy card or voting instruction card and do not attend the Annual Meeting?
|
|
A:
|
If you do not vote your shares held of record (registered directly in your name, not in the name of a broker, bank or nominee), your shares will not be voted.
|
|
Q:
|
How are votes counted?
|
|
A:
|
For the election of directors, you may vote “FOR” all or some of the nominees or your vote may be “WITHHELD” with respect to one or more of the nominees. For the Auditor Ratification Proposal you may vote “FOR” or “AGAINST” the proposal or you may “ABSTAIN” from voting on such proposal.
|
|
Q:
|
What are the voting requirements with respect to the election of directors?
|
|
A:
|
In the election of directors, each director nominee receiving a plurality of the votes of shares present and entitled to vote at the Annual Meeting will be elected. You may withhold votes from any or all nominees.
|
|
Q:
|
How many votes do I have?
|
|
A:
|
You are entitled to one vote for each share of common stock, $0.01 par value per share, of the Company (the “Common Stock”) that you hold. As of the Record Date, there were 5,870,302 shares of Common Stock issued and outstanding.
|
|
Q:
|
What happens if a director nominee does not stand for election?
|
|
A:
|
If for any reason any nominee does not stand for election, any proxies we receive will be voted in favor of the remainder of the nominees and may be voted for substitute nominees in place of those who do not stand. We have no reason to expect that any of the nominees will not stand for election.
|
|
Q:
|
What happens if additional matters are presented at the Annual Meeting?
|
|
A:
|
Other than the seven items of business described in this Proxy Statement, we are not aware of any other business to be brought before the Annual Meeting. If you grant a proxy, the person named as proxy holder and John P. Murray will have the discretion to vote your shares on any additional matters properly presented for a vote at the Annual Meeting.
|
|
Q:
|
How many shares must be present or represented to conduct business at the Annual Meeting?
|
|
A:
|
A quorum will be present if at least a majority of the outstanding shares of our Common Stock entitled to vote at the Annual Meeting, totaling 2,935,152 shares, is represented at the Annual Meeting, either in person or by proxy.
|
|
Q:
|
How can I attend and vote my shares in person at the Annual Meeting?
|
|
A:
|
You are entitled to attend the Annual Meeting only if you were a stockholder as of the close of business on the Record Date, or you hold a valid proxy for the Annual Meeting. You should be prepared to present photo identification for admittance. In addition, if you are a stockholder of record, your name will be verified against the list of stockholders of record on the Record Date prior to your being admitted to the Annual Meeting. If you are not a stockholder of record but hold shares through a broker, bank or nominee (i.e., in street name), and you plan to attend the Annual Meeting, please send written notification to Wilhelmina International, Inc., 200 Crescent Court, Suite 1400, Dallas, Texas 75201, Attn: Corporate Secretary, and enclose evidence of your ownership (such as your most recent account statement prior to the Record Date, a copy of the voting instruction card provided by your broker, bank or nominee, or other similar evidence of ownership). If you do not provide photo identification or comply with the other procedures outlined above, you will not be admitted to the Annual Meeting.
|
|
Q:
|
How can I vote my shares in person at the Annual Meeting?
|
|
A:
|
Shares held in your name as the stockholder of record may be voted in person at the Annual Meeting. Shares held beneficially in street name may be voted in person at the Annual Meeting only if you obtain a legal proxy from the broker, bank or nominee that holds your shares giving you the right to vote the shares. Even if you plan to attend the Annual Meeting, we recommend that you also submit your proxy card or voting instruction card as described herein so that your vote will be counted if you later decide not to attend the Annual Meeting.
|
|
Q:
|
What is the deadline for voting my shares?
|
|
A:
|
If you hold shares as the stockholder of record, your vote by proxy must be received before the polls close at the Annual Meeting.
|
|
Q:
|
Is my vote confidential?
|
|
A:
|
Proxy instructions, ballots and voting tabulations that identify individual stockholders are handled in a manner that protects your voting privacy. Your vote will not be disclosed either within the Company or to third parties, except (a) as necessary to meet applicable legal requirements, (b) to allow for the tabulation of votes and certification of the vote, and (c) to facilitate a successful proxy solicitation. Occasionally, stockholders provide written comments on their proxy card, which are then forwarded to our management.
|
|
Q:
|
Where can I find the voting results of the Annual Meeting?
|
|
A:
|
We intend to announce preliminary voting results at the Annual Meeting and publish final voting results in a Current Report on Form 8-K to be filed with the U.S. Securities and Exchange Commission (the “SEC”) within four business days after the Annual Meeting.
|
|
Q:
|
How may I obtain a copy of the 2013 Annual Report and other financial information?
|
|
A:
|
A copy of the 2013 Annual Report is enclosed.
|
|
Q:
|
What if I have questions for the Transfer Agent?
|
|
A:
|
Please contact the Transfer Agent, at the telephone number or address listed below, with questions concerning stock certificates, transfer of ownership or other matters pertaining to your stock account.
|
|
Q:
|
Who can help answer my questions?
|
|
A:
|
If you have any questions about the Annual Meeting or how to vote or revoke your proxy, you should contact us at:
|
|
(a)
|
each person who is known by us to beneficially own 5% or more of the Common Stock;
|
|
(b)
|
each of our directors, nominees and named executive officers; and
|
|
(c)
|
all of our directors, nominees and executive officers as a group.
|
|
Common Stock
|
|||||
|
Name of Beneficial Owner
|
Shares
|
%
(1)
|
|||
|
5% or Greater Stockholders
|
|||||
|
Newcastle Partners, L.P.
(2)
|
2,430,725
(3)
|
41.4
|
|||
|
Horst-Dieter Esch
(4)
|
1,441,395
(5)
|
24.6
|
|||
|
Directors, Nominees and Named Executive Officers
|
|||||
|
Mark E. Schwarz
|
2,430,725
(6)
|
41.4
|
|||
|
Alex Vaickus
|
65,000
(7)
|
*
|
|||
|
John Murray
|
0
|
-
|
|||
|
Horst-Dieter Esch
|
1,441,395
(8)
|
24.6
|
|||
|
Clinton Coleman
|
0
|
-
|
|||
|
James Dvorak
|
0
|
-
|
|||
|
Mark Pape
|
0
|
-
|
|||
|
Jeffrey Utz
|
0
|
-
|
|||
|
James Roddey
|
0
|
-
|
|||
|
All directors, nominees and executive officers as a group (ten persons)
|
3,937,120
(9)
|
66.4
|
|||
|
*
|
Less than 1%
|
|
(1)
|
Based on 5,870,302 shares of Common Stock outstanding as of the Record Date. With the exception of shares that may be acquired by employees pursuant to our 401(k) retirement plan, a person is deemed to be the beneficial owner of Common Stock that can be acquired within 60 days after the Record Date upon the exercise of options. Each beneficial owner’s percentage ownership of Common Stock is determined by assuming that options that are held by such person, but not those held by any other person, and that are exercisable within 60 days after the Record Date have been exercised.
|
|
(2)
|
The business address of Newcastle Partners, L.P. (“Newcastle”) is 200 Crescent Court, Suite 1400, Dallas, Texas 75201.
|
|
(3)
|
Consists of shares of Common Stock held by Newcastle, as disclosed in Amendment No. 9 to a Schedule 13D filed with the SEC on June 19, 2014. Newcastle Capital Management, L.P. (“NCM”), as the general partner of Newcastle, may be deemed to beneficially own the shares held by Newcastle. Each of Newcastle Capital Group, L.L.C. (“NCG”), as the general partner of NCM, NCM Services Inc. (“NCM Services”), as the sole member of NCG, the Schwarz 2012 Family Trust (the “Schwarz Trust”), as the sole stockholder of NCM Services, and Mark E. Schwarz, as the sole trustee of the Schwarz Trust, may in each case also be deemed to beneficially own the shares held by Newcastle. Each of NCM, NCG, NCM Services, the Schwarz Trust and Mr. Schwarz disclaims beneficial ownership of the shares held by Newcastle except to the extent of their pecuniary interest therein.
|
|
(4)
|
The business address of Horst-Dieter Esch is Carretera Transpeninsular Km. 27.5, San Jose del Cabo, B.C.S. Mexico 23400.
|
|
(5)
|
Consists of 1,423,404 shares of Common Stock held of record by Horst-Dieter Esch and 10,451 shares of Common Stock held of record by Lorex Investment AG (“Lorex”), in each case as reported to the Company by its transfer agent as of November 14, 2014, and 7,540 shares of Common Stock held by Horst-Dieter Esch, as disclosed in a Statement of Changes in Beneficial Ownership on Form 4 filed with the SEC by Horst-Dieter Esch on June 27, 2014. Mr. Esch is the sole stockholder of Lorex and shares voting and dispositive power over the shares held by Lorex with Peter Marty, its sole officer and director.
|
|
(6)
|
Consists of 2,430,725 shares of Common Stock held by Newcastle. Mr. Schwarz may be deemed to beneficially own the shares held by Newcastle by virtue of his power to vote and dispose of such shares. Mr. Schwarz disclaims beneficial ownership of the shares held by Newcastle except to the extent of his pecuniary interest therein.
|
|
(7)
|
Includes 60,000 shares of Common Stock issuable upon the exercise of options held by Alex Vaickus individually, which are exercisable within 60 days after the Record Date.
|
|
(8)
|
Consists of 1,430,944 shares of Common Stock held by Horst-Dieter Esch and 10,451 shares of Common Stock held by Lorex. Mr. Esch is the sole stockholder of Lorex and shares voting and dispositive power over the shares held by Lorex with Peter Marty, its sole officer and director.
|
|
(9)
|
Consists of 3,877,120 shares of Common Stock and 60,000 shares of Common Stock issuable upon the exercise of options.
|
|
Name
|
Age
|
Positions with Company
|
|
Mark E. Schwarz
|
54
|
Chairman of the Board and Executive Chairman
|
|
Clinton Coleman
|
37
|
Director
|
|
James Dvorak
|
45
|
Director
|
|
Horst-Dieter Esch
|
71
|
Director
|
|
Mark Pape
|
64
|
Director
|
|
James Roddey
|
80
|
Director
|
|
Jeffrey Utz
|
48
|
Director
|
|
Alex Vaickus
|
55
|
Chief Executive Officer
|
|
John Murray
|
45
|
Chief Financial Officer
|
|
Name and Principal Position
|
Year
|
Salary ($)
|
Bonus ($)
|
Option
Awards
($)
|
All Other
Compensation ($)
|
Total ($)
|
||||||||||||||||
|
Mark E. Schwarz
|
2013
|
150,000 | - | - | - | 150,000 | ||||||||||||||||
|
Executive Chairman and
Former Chief Executive
Officer
(1)
|
2012
|
150,000 | - | - | - | 150,000 | ||||||||||||||||
|
Alex Vaickus
|
2013
|
500,000 | - | 273,034 | (3) | - | 773,034 | |||||||||||||||
|
Chief Executive Officer
(2)
|
2012
|
135,416 | - | 357,416 | (3) | - | 492,832 | |||||||||||||||
|
John Murray
|
2013
|
200,000 | - | - | - | 275,000 | ||||||||||||||||
|
Chief Financial Officer
|
2012
|
200,000 | 75,000 | (4) | - | - | 275,000 | |||||||||||||||
|
(1)
|
Mr. Schwarz served as Chief Executive Officer throughout 2011 and from January 1, 2012 through September 25, 2012, at which time he assumed the title of Executive Chairman.
|
|
(2)
|
Mr. Vaickus was appointed Chief Executive Officer on September 25, 2012.
|
|
(3)
|
In connection with his appointment as Chief Executive Officer, Mr. Vaickus was awarded an option to purchase 100,000 shares of our Common Stock with an exercise price of $2.34 per share, a five year vesting schedule (vesting in equal annual increments beginning on the first anniversary of the date of the grant) and a ten year term. On September 27, 2013 Mr. Vaickus was awarded an additional option to purchase 100,000 shares of our Common Stock with an exercise price of $3.80 per share, a five year vesting schedule (vesting in equal annual increments beginning on the first anniversary of the date of the grant) and a ten year term These options were granted under the Company’s 2011 Incentive Plan. Amount reflects the fair value of the option grants estimated on the date of grant using the Black-Scholes option pricing model.
|
|
(4)
|
Represents a cash bonus paid to Mr. Murray.
|
|
Option Awards
|
||||||||||||||||
|
Name
|
Number of Securities Underlying Unexercised Options (#) Exercisable
|
Number of Securities Underlying Unexercised Options (#) Unexercisable
|
Option Exercise Price
($)
|
Option Expiration Date
|
||||||||||||
|
Mark E. Schwarz
|
- | - | - | - | ||||||||||||
|
Alex Vaickus
|
40,000 | 60,000 | (1) | 2.34 |
9/25/22
|
|||||||||||
| 20,000 | 80,000 | (2) | 3.80 |
9/27/23
|
||||||||||||
|
John Murray
|
2,500 | - | 5.60 |
6/18/14
|
||||||||||||
|
(1)
|
options were granted September 25, 2012 and vest in annual installments of 20,000 on each anniversary.
|
|
(2)
|
options were granted September 27, 2013 and vest in annual installments of 20,000 on each anniversary.
|
|
Name
|
Fees Earned or Paid in Cash ($)
|
All Other Compensation ($)
|
Total ($)
|
|||||||||
|
Horst-Dieter Esch
|
28,000 | - | 28,000 | |||||||||
|
Jeffrey Utz
(1)
|
7,000 | - | 7,000 | |||||||||
|
Clinton Coleman
|
28,000 | - | 28,000 | |||||||||
|
James Dvorak
|
28,000 | - | 28,000 | |||||||||
|
Mark Pape
|
28,000 | - | 28,000 | |||||||||
|
James Roddey
(2)
|
28,000 | - | 28,000 | |||||||||
|
(1)
|
Elected to the Board September 2013.
|
|
(2)
|
Mr. Roddey was not a Board nominee for the 2013 Annual Meeting held on September 26, 2013 and accordingly ceased to serve on the Board as of the 2013 Annual Meeting. Mr. Roddey was subsequently re-appointed to the Board on November 19, 2013. The Company does not pro-rate quarterly cash fees assuming the director serves for a material portion of the applicable quarter.
|
|
Plan Category
|
Number of securities to be issued upon exercise of outstanding options, warrants and rights
(a)
|
Weighted average exercise price of outstanding options, warrants and rights
(b)
|
Number of securities remaining available for future issuance under equity compensation plans (excluding securities reflected in column (a))
(c)
|
|||||||||
|
Equity compensation plans approved by security holders
|
202,500 | $ | 3.00 | 100,000 | ||||||||
|
Equity compensation plans not approved by security holders
|
n/a | n/a | n/a | |||||||||
|
Total
|
202,500 | $ | 3.00 | 100,000 | ||||||||
|
AUDIT COMMITTEE
|
|
|
Mark Pape (Chairman)
|
|
|
James Roddey
Jeffrey Utz
|
|
1.
|
To elect seven directors to serve until the next Annual Meeting of Stockholders and until their successors are duly elected and qualify.
|
|
FOR ALL NOMINEES [ ]
|
WITHHOLD AUTHORITY TO [ ]
|
FOR ALL NOMINEES EXCEPT [ ]
|
|
|
VOTE FOR ALL NOMINEES
|
|
Nominees:
|
01 Clinton Coleman
|
05 Mark E. Schwarz
|
|
|
02 James Dvorak
|
06 Jeffrey Utz
|
||
|
03 Horst-Dieter Esch
|
07 James Roddey
|
||
|
04 Mark Pape
|
|
2.
|
To approve a proposal to ratify the appointment of Montgomery Coscia Greilich, LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2014.
|
|
FOR [ ]
|
AGAINST [ ]
|
ABSTAIN [ ]
|
|
|
|
(Print Full Name of Stockholder)
|
|
(Signature of Stockholder)
|
|
(Signature if held jointly)
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|